Carl W. Baker

3.4k total citations · 2 hit papers
26 papers, 1.7k citations indexed

About

Carl W. Baker is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and General Health Professions. According to data from OpenAlex, Carl W. Baker has authored 26 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Ophthalmology, 18 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in General Health Professions. Recurrent topics in Carl W. Baker's work include Retinal Diseases and Treatments (22 papers), Retinal Imaging and Analysis (17 papers) and Glaucoma and retinal disorders (9 papers). Carl W. Baker is often cited by papers focused on Retinal Diseases and Treatments (22 papers), Retinal Imaging and Analysis (17 papers) and Glaucoma and retinal disorders (9 papers). Carl W. Baker collaborates with scholars based in United States, Spain and Italy. Carl W. Baker's co-authors include Adam R. Glassman, Lee M. Jampol, Jennifer K. Sun, Andrew N. Antoszyk, Cynthia R. Stockdale, Michael J. Elman, Michele Melia, Neil M. Bressler, Frederick L. Ferris and Kelly D. Brownell and has published in prestigious journals such as New England Journal of Medicine, JAMA and Ophthalmology.

In The Last Decade

Carl W. Baker

26 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy

2015 529 citations Jeffrey G. Gross, Adam R. Glassman et al. JAMA profile →
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy

2018 262 citations Jeffrey G. Gross, Adam R. Glassman et al. JAMA Ophthalmology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carl W. Baker United States	15	1.5k	1.3k	162	85	78	26	1.7k
Allison R. Edwards United States	12	2.1k 1.4×	1.7k 1.3×	189 1.2×	7 0.1×	43 0.6×	14	2.4k
Hyung Woo Kwak South Korea	15	731 0.5×	463 0.4×	93 0.6×	6 0.1×	56 0.7×	61	989
Ortrud Gerstner Germany	5	1.3k 0.9×	1.1k 0.9×	133 0.8×	7 0.1×	22 0.3×	5	1.4k
Seyed-Hossein Abtahi Iran	14	204 0.1×	113 0.1×	77 0.5×	15 0.2×	61 0.8×	50	698
Eun Jee Chung South Korea	17	862 0.6×	703 0.6×	140 0.9×	3 0.0×	39 0.5×	58	1.1k
David Wirta United States	17	366 0.2×	213 0.2×	56 0.3×	9 0.1×	426 5.5×	44	762
Chunxia Li China	10	353 0.2×	294 0.2×	141 0.9×	4 0.0×	13 0.2×	18	602
Paul Beaumont Australia	14	652 0.4×	490 0.4×	100 0.6×	2 0.0×	38 0.5×	26	777
Mark Cahill Ireland	15	574 0.4×	397 0.3×	132 0.8×	2 0.0×	22 0.3×	33	846
Yasutaka Kimura Japan	9	227 0.2×	102 0.1×	96 0.6×	28 0.3×	32 0.4×	18	374

Countries citing papers authored by Carl W. Baker

Since Specialization

Citations

This map shows the geographic impact of Carl W. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl W. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl W. Baker more than expected).

Fields of papers citing papers by Carl W. Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl W. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl W. Baker. The network helps show where Carl W. Baker may publish in the future.

Co-authorship network of co-authors of Carl W. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Carl W. Baker. A scholar is included among the top collaborators of Carl W. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl W. Baker. Carl W. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baker, Carl W., Kristin Josic, Maureen G. Maguire, et al.. (2022). Comparison of Snellen Visual Acuity Measurements in Retinal Clinical Practice to Electronic ETDRS Protocol Visual Acuity Assessment. Ophthalmology. 130(5). 533–541. 8 indexed citations

Jhaveri, Chirag, Adam R. Glassman, Frederick L. Ferris, et al.. (2022). Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema. New England Journal of Medicine. 387(8). 692–703. 49 indexed citations

Sun, Jennifer K., Carl W. Baker, & Lee M. Jampol. (2022). A Step Forward in Understanding Treatment Approaches for Diabetic Macular Edema. JAMA Ophthalmology. 141(1). 9–9. 2 indexed citations

Kim, Judy E., Adam R. Glassman, Kristin Josic, et al.. (2021). A Randomized Trial of Photobiomodulation Therapy for Center-Involved Diabetic Macular Edema with Good Visual Acuity (Protocol AE). Ophthalmology Retina. 6(4). 298–307. 25 indexed citations

Beaulieu, Wesley T., Adam R. Glassman, Carl W. Baker, et al.. (2021). Effect of Initial Aflibercept, Laser, or Observation on Low-Contrast Visual Acuity in Eyes With Diabetic Macular Edema and Good Vision: Ancillary Study Within a Randomized Clinical Trial. Translational Vision Science & Technology. 10(3). 3–3. 6 indexed citations

Glassman, Adam R., John A. Wells, Kristin Josic, et al.. (2020). Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study). Ophthalmology. 127(9). 1201–1210. 106 indexed citations

Maguire, Maureen G., Danni Liu, Adam R. Glassman, et al.. (2020). Visual Field Changes Over 5 Years in Patients Treated With Panretinal Photocoagulation or Ranibizumab for Proliferative Diabetic Retinopathy. JAMA Ophthalmology. 138(3). 285–285. 34 indexed citations

Glassman, Adam R., Carl W. Baker, Wesley T. Beaulieu, et al.. (2020). Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity. JAMA Ophthalmology. 138(4). 341–341. 31 indexed citations

Gross, Jeffrey G., Adam R. Glassman, Danni Liu, et al.. (2018). Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy. JAMA Ophthalmology. 136(10). 1138–1138. 262 indexed citations breakdown →

10.

Antoszyk, Andrew N., et al.. (2018). Usability of the Ranibizumab 0.5 mg Prefilled Syringe: Human Factors Studies to Evaluate Critical Task Completion by Healthcare Professionals. PDA Journal of Pharmaceutical Science and Technology. 72(4). 411–419. 4 indexed citations

11.

Ip, Michael S., Neal L. Oden, Ingrid U. Scott, et al.. (2018). Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion. JAMA Ophthalmology. 137(3). 281–281. 11 indexed citations

12.

Baker, Carl W., et al.. (2018). Recruitment and retention of GPs. 1 indexed citations

13.

Jampol, Lee M., Adam R. Glassman, Carl W. Baker, et al.. (2017). PANRETINAL PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY. Retina. 39(1). 69–78. 8 indexed citations

14.

Yang, Yit C., Clare Bailey, Frank G. Holz, et al.. (2015). Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants. Eye. 29(9). 1173–1180. 40 indexed citations

15.

Gross, Jeffrey G., Adam R. Glassman, Lee M. Jampol, et al.. (2015). Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy. JAMA. 314(20). 2137–2137. 529 indexed citations breakdown →

16.

Wells, John A., Adam R. Glassman, Lee M. Jampol, et al.. (2015). Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema. JAMA Ophthalmology. 134(2). 127–127. 63 indexed citations

17.

Friedman, Scott M., Talat Almukhtar, Carl W. Baker, et al.. (2015). TOPICAL NEPAFENEC IN EYES WITH NONCENTRAL DIABETIC MACULAR EDEMA. Retina. 35(5). 944–956. 64 indexed citations

18.

Bressler, Susan B., Carl W. Baker, Talat Almukhtar, et al.. (2013). Pilot Study of Individuals With Diabetic Macular Edema Undergoing Cataract Surgery. JAMA Ophthalmology. 132(2). 224–224. 14 indexed citations

19.

Pearson, P. Andrew, Carl W. Baker, Dean Eliott, et al.. (2003). Fluocinolone Acetonide Intravitreal Implant in Patients with Diabetic Macular Edema: 12 Month Results. Investigative Ophthalmology & Visual Science. 44(13). 4288–4288. 4 indexed citations

20.

Ward, Kimberly A., et al.. (1991). Red blood cell deformability: Effect of age and smoking. AGE. 14(3). 73–77. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact